On-X Life Technologies begins shipping its On-X® Plus 1.5™ Aortic Heart Valve to European hospitals “While the On-X® Plus 1.5™ Aortic Heart Valve allows European clinicians for the first time to manage their patients on a reduced dose of warfarin. Our launch of this important new heart valve builds upon our 18 years of service […]
US FDA Aortic Valve Approval
May 30, 2001 By
MCRI is awarded FDA premarket approval for its On-X aortic valve AUSTIN, TX — May 30, 2001 – MCRI is awarded FDA premarket approval for its On-X aortic valve, making the valve available to patients in the United States. Mitral valve approval is expected to follow pending additional follow-up.